Araim Pharmaceuticals, Inc. — Form D/A

Araim Pharmaceuticals, Inc. of TARRYTOWN, NY, a company, filed a Form D amendment with the SEC on 2017-11-15. The offering totals $4.1M, of which $4.1M was reported sold. Industry: Pharmaceuticals.

Offering

• Filed: 2017-11-15
• Form: D/A
• Accession: 0001625178-17-000002
• Industry: Pharmaceuticals
• Exemptions: 06b
• Total offering: $4.1M
• Amount sold: $4.1M
• Investors: 5
• Date of first sale: 2017-08-29
• Security types: debt
• Revenue range: Decline to Disclose
• SEC file number: 021-294624

Issuer

• Name: Araim Pharmaceuticals, Inc.
• CIK: 0001625178
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Address: 580 WHITE PLAINS ROAD, SUITE 210, TARRYTOWN, NY, 10591
• Phone: 914-762-7586

Officers, directors & promoters (13)

Other filings by this issuer (2)

More

• CIK 1625178 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search